JS Group

International Expansion Consultants Corporate Intelligence & Lead Generation Medical Innovation Marketing

[JS Group @JSGroupGlobal]

JS Medical is delighted to announce it has been appointed as @RenalGuard's new UK & Ireland distributor, building on our expertise promoting RenalGuard therapy in EMEA region #cardiology #nephropathy @JSGroupGlobal https://t.co/PBIv4M2KaO

[JS Group @JSGroupGlobal]

UKRP Services

[JS Group @JSGroupGlobal]

https://t.co/g2E6K5hjLO

[NICE @NICEComms]

NICE did not develop or endorse the COVID-19 decision support tool claimed in some media articles today. Nor did NICE develop the Clinical Frailty Score, however we have recommended its use in our COVID-19 guideline on critical care in adults in whom it has been validated.

[Profusa @ProfusaInc]

We are excited to share data on the use of our biosensor technology in clinical management at #LINC2020. Visit us at booth 34 to learn more.

[Murat Celebi @muratcelebi]

#LINC2020 #Shockwave

[JS Group @JSGroupGlobal]

#ArabHealth2020

[JS Group @JSGroupGlobal]

JS Group is participating at Linc 2020. #LINC2020

[JS Group @JSGroupGlobal]

JS Group is participating at ArabHealth 2020. #ArabHealth2020

[JS Group @JSGroupGlobal]

Reprieve Cardiovascular reports results of fluid management trial https://t.co/Q8duRiidUi via @MedicalTechMag

[MCT Lifesciences UK @MCTLSUK]

https://t.co/yCwIy0Bfr7

[JS Group @JSGroupGlobal]

JS Medical provided RenalGuard clinical training to the cath-lab and radiology staff at Lincoln County Hospital. The session was well attended and much appreciated by the staff.

[JS Group @JSGroupGlobal]

#EMDA #bladdercancer

[JS Group @JSGroupGlobal]

The JS Medical team at the BAUS Oncology conference in Brighton. How can we help you during the shortage of Mitomycin-C? Come and talk to us.

[JS Group @JSGroupGlobal]

The JS Medical team at the BAUS Oncology conference in Brighton. How can we help you during the shortage of Mitomycin-C? Come and talk to us.

[JS Group @JSGroupGlobal]

D-1 to #BAUS #Oncology 2019 - looking forward to meeting esteemed colleagues and new contacts and presenting latest silicone urogenics electrode catheter design as part of EMDA treatment @BAUSurology #EMDA #catheter #urogenics #urologyhealth #healthcare https://t.co/psTHKfVOCK

[JS Group @JSGroupGlobal]

D-2 before the start of #BAUS #Oncology 2019 - if you are planning to be in Brighton, visit our stand for info on using EMDA to treat Peyronie's Disease, UTIs, Interstitial Cystitis @BAUSurology #EMDA #Peyronie #UTI #Cystitis #urologyhealth #healthcare https://t.co/psTHKfVOCK

[JS Group @JSGroupGlobal]

Counting down to #BAUS #Oncology starting on Thursday in Brighton....Visit JS Medical stand to see latest trial results that show sequential BCG+EMDA-MMC treatment is twice as effective as BCG alone @BAUSurology #EMDA #MMC #BCG #urologyhealth #healthcare https://t.co/psTHKfVOCK

[JS Group @JSGroupGlobal]

Counting down to #BAUS #Oncology in Brighton next week.... Visit our stand to see latest trial results showing sequential BCG+EMDA-MMC treatment is twice as effective as BCG alone @BAUSurology #EMDA #MMC #BCG #urologyhealth #healthcare https://t.co/psTHKfVOCK

[JS Group @JSGroupGlobal]

Are you attending the #BAUS Section of #Oncology Meeting in Brighton on 21-22 Nov? JS Medical will be exhibiting the #EMDA drug delivery system - the alternative treatment if #BCG is in short supply @BAUSurology #MMC #urologyhealth #healthcare https://t.co/psTHKfVOCK

[JS Group @JSGroupGlobal]

Not just well-tolerated EMDA is cost-effective & easy to use. Find out why your clinic should be offering the sequential BCG+EMDA-MMC treatment protocol at #BAUS #Oncology meeting Brighton. @GSTTnhs @BAUSurology #EMDA #MMC #BCG #urologyhealth #healthcare https://t.co/psTHKfVOCK

[JS Group @JSGroupGlobal]

Guy's Hospital study shows if induction BCG/EMDA-MMC treatment completed, 2/3 of patients remain disease-free. Visit our stand at #BAUS #Oncology meeting Brighton for info. @GSTTnhs @BAUSurology #EMDA #MMC #BCG #urologyhealth #healthcare https://t.co/psTHKfVOCK